Pluto Bio的封面图片
Pluto Bio

Pluto Bio

软件开发

Denver,CO 1,432 位关注者

The intuitive, multi-omics drug discovery platform. Analyze data, integrate literature, and reach milestones faster.

关于我们

Drug discovery just got a modern upgrade. Pluto is the collaborative, AI-powered solution empowering scientific teams to do target and biomarker discovery, faster than ever before. Build your biomarker and target lists, track status, priority, and evidence in powerful reports. Visualize and analyze multi-omics data sets with no coding required, and create compelling figures for high-impact presentations. Integrate the wealth of knowledge from published literature and data sets to gain a competitive advantage and derisk projects earlier for better results.

网站
https://pluto.bio
所属行业
软件开发
规模
2-10 人
总部
Denver,CO
类型
私人持股
创立
2020
领域
Multi-omics、Target discovery、Biomarker discovery、Scientific communication、Data visualization、Proprietary knowledgebase和Literature integration

地点

Pluto Bio员工

动态

  • 查看Pluto Bio的组织主页

    1,432 位关注者

    Seamlessly sync results from your multi-omics analysis in Pluto ?? Benchling for end-to-end traceability. Connected R&D that empowers scientists ??

    查看Benchling的组织主页

    48,280 位关注者

    We get it. It's not uncommon for R&D teams to use dozens of scientific software apps — but that doesn’t mean it has to be difficult to build a connected R&D ecosystem. That’s why we’re working with industry partners to build a growing library of out-of-the-box integrations, so you can easily move your data back and forth. Check out this selection of 3rd party apps where a Benchling integration is available. ?? Learn about our developer tools: https://lnkd.in/gqvh5fpC #FeatureFriday

    • 该图片无替代文字
  • 查看Pluto Bio的组织主页

    1,432 位关注者

    We're about one month out from the AACR Annual Meeting 2025! If your Biology or Translational team is interested in using transcriptomics, proteomics, and other data for #targetdiscovery or #biomarkerdiscovery, don't miss out on the opportunity to talk with our experts. Set up a meeting with Pluto founder & CEO Rani Powers, PhD to discuss partnering opportunities, and come try our intuitive platform for yourself with Caitlin Winkler and Jim Hanifen doing live demos at booth #3907 ?? Reach out at [email protected] or https://pluto.bio/get-info to get started! #AACR25 #AACR2025

    • 该图片无替代文字
  • 查看Pluto Bio的组织主页

    1,432 位关注者

    Comparing data sets side-by-side is common in the exploratory stages of analysis, and it's also valuable as you're laying out your a final scientific story. Pluto's interactive figure canvas enables you to instantly pull in results from multiple data sets. Rather than laying out static graphs in a slide deck, in Pluto, the multi-panel figures you create stay live and up-to-date when updates are made to any of the plots. Check it out: https://lnkd.in/gSDCQ4rN #multiomics #drugdiscovery

  • 查看Pluto Bio的组织主页

    1,432 位关注者

    At Pluto, our mission is to empower scientists to explore and learn from their own data. One of the main barriers preventing more companies from leveraging single cell data in their target discovery is uncertainty about how to interpret the vast amount of information in a single study. A helpful step towards clear interpretation begins with how you annotate the clusters identified in a scRNA-seq data set. You can use a variety of approaches for this, including both manual steps (domain expertise) and automated/ML/AI approaches. Read the guide authored by the single cell experts at Pluto to get a foundational understanding of cluster annotation, perfect for scientists aiming to leverage scRNA-seq for target and biomarker discovery ?? https://lnkd.in/gD76-VMD #scRNAseq #bioinformatics #targetdiscovery

    • 该图片无替代文字
  • 查看Pluto Bio的组织主页

    1,432 位关注者

    Scientific exploration isn't linear, especially when it comes to investigating multi-omics data. Break free from slides and notebooks - let novel scientific ideas flow into your unique story with Pluto's analysis canvas ? Add data from multiple assays (RNA-seq, proteomics, epigenetics...) and results from multiple sources (built-in visualizations, custom scripts) to create a unified, powerful exploration into all of the data in your study. Plus, invite your whole team to collaborate on discoveries in real-time. Speak to our scientists to learn more: https://lnkd.in/gHpz9r2X

  • 查看Pluto Bio的组织主页

    1,432 位关注者

    Congratulations to the Children's Tumor Foundation and SpringWorks Therapeutics on the FDA's approval of Gomekli (mirdametinib) - the second-ever FDA-approved treatment for NF1 and first-ever approved treatment for adults. We're celebrating this incredible milestone for patients, who now have another treatment option thanks to your scientific innovation & dedication! #EndNF

    查看Children's Tumor Foundation的组织主页

    7,175 位关注者

    IT’S A GO! NF’s NEXT BIG WIN! ?? ?? Today, we make history... again! The FDA has officially approved Gomekli (mirdametinib) - the second-ever FDA-approved treatment for NF1 and the first-ever for adults! This is a game-changing moment for the NF community. For years, patients and families have waited for more treatment options. Today, that wait gets shorter. Click here to read more → https://lnkd.in/gAhfGeYR “We are excited to celebrate the extraordinary milestone of our partners and long-term friends at SpringWorks Therapeutics for the NF community. This FDA approval shows the power of collaboration to advance innovative science for drugs that may otherwise not have been taken forward,” said Annette Bakker, PhD, Chief Executive Officer of the Children’s Tumor Foundation. “When industry, researchers, and organizations like ours driving treatment innovation join forces, scientific progress moves faster, and patients gain access to the therapies they need. Every treatment approval is hard-won, built on research, persistence, and partnership. Today, that work delivers a critical new option for NF patients of all ages.” Breakthroughs like this don’t happen without YOU. Every patient who participated in a trial, every researcher who pursued new possibilities, and every donor who fueled this work helped make this moment possible. Because of you, NF patients now have another treatment option - and hope for more to come. Join Us to Celebrate! To mark this milestone, we’re hosting a special virtual gathering - a chance to come together, celebrate what this means for the NF community, and talk about what’s next. Date & Time: Friday, Feb. 14, 2025 12PM ET Register Here: https://lnkd.in/gjUKHbnA #EndNF Children's Tumor Foundation Europe

    • 该图片无替代文字
  • 查看Pluto Bio的组织主页

    1,432 位关注者

    Why measure protein abundance? Proteomics is a powerful tool in target discovery, drug development, and biomarker identification. In particular, proteomics is important because gene expression (e.g. mRNA levels measured by RNA-seq) and protein levels (proteomics) aren’t always correlated. Why is that? ?? There are different, complex networks responsible for regulating mRNA and protein. In some cases, a gene may be highly expressed at the transcript level, but the protein is expressed at a very low level or vice versa. #Multiomics approaches combining transcriptomics and proteomics offer a unique perspective into the biology. Learn more about #proteomics in this primer for translational scientists: https://lnkd.in/gh5wGRgU

    • 该图片无替代文字

相似主页

查看职位